Avacta Life Sciences Ltd
Clinical trials sponsored by Avacta Life Sciences Ltd, explained in plain language.
-
Smart chemo aims to hit tumors harder, spare healthy cells
Disease control Recruiting nowThis early-stage trial tests a new drug, AVA6000, designed to deliver chemotherapy directly to tumor cells while reducing harm to healthy tissue. It is for people with advanced solid tumors (like breast, ovarian, or salivary gland cancer) that have not responded to standard treat…
Phase: PHASE1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control
Last updated May 26, 2026 02:26 UTC
-
New drug targets tumors directly in early trial
Disease control Recruiting nowThis early-phase trial tests a new drug called AVA6103 in about 144 people with advanced solid tumors (like pancreatic, stomach, or lung cancer) that have not responded to standard treatments. The drug is designed to activate only inside tumors to kill cancer cells while limiting…
Phase: PHASE1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control
Last updated May 06, 2026 16:03 UTC